Mr. Philippe Dubuc reports

THERATECHNOLOGIES TO ANNOUNCE THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE

Theratechnologies Inc. will release financial results and provide a business update for its third quarter ended Aug. 31, 2024, on Thursday, Oct. 10, 2024, at 8:30 a.m. ET.

The call will be hosted by Paul Levesque, president and chief executive officer. He will be joined by other members of the management team, including: Philippe Dubuc, senior vice-president and chief financial officer, Dr. Christian Marsolais, PhD, senior vice-president and chief medical officer, and John Leasure, global commercial officer, who will be available to answer questions from participants following prepared remarks.

Participants are encouraged to join the call at least 10 minutes in advance to secure access. Conference call dial-in and replay information can be found herein.

Conference call information

Conference call date:  Oct. 10, 2024

Conference call time:  8:30 a.m. ET

Dial-in numbers:  1-888-513-4119 (toll-free) or 1-412-902-6615 (international)

Access code:  5313857

Conference call replay

Toll-free numbers:  1-877-344-7529 (United States)/1-855-669-9658 (Canada)

International toll number:  1-412-317-0088

Replay access code:  2159194

Replay end date:  Oct. 17, 2024

An archived webcast will also be available on the company's investor relations website.

About Theratechnologies Inc.

Theratechnologies is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs.